ENL Stock Overview
Operates in the healthcare IT sector in the United States, Europe, and Japan.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 5/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Enlitic, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | AU$0.40 |
| 52 Week High | AU$1.01 |
| 52 Week Low | AU$0.40 |
| Beta | 0 |
| 1 Month Change | -33.33% |
| 3 Month Change | -43.66% |
| 1 Year Change | n/a |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -52.94% |
Recent News & Updates
Recent updates
Shareholder Returns
| ENL | AU Healthcare Services | AU Market | |
|---|---|---|---|
| 7D | -20.0% | 1.4% | 0.7% |
| 1Y | n/a | 74.6% | 7.8% |
Return vs Industry: Insufficient data to determine how ENL performed against the Australian Healthcare Services industry.
Return vs Market: Insufficient data to determine how ENL performed against the Australian Market.
Price Volatility
| ENL volatility | |
|---|---|
| ENL Average Weekly Movement | n/a |
| Healthcare Services Industry Average Movement | 7.7% |
| Market Average Movement | 9.0% |
| 10% most volatile stocks in AU Market | 17.6% |
| 10% least volatile stocks in AU Market | 3.4% |
Stable Share Price: ENL's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine ENL's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2014 | n/a | Michael Sistenich | www.enlitic.com |
Enlitic, Inc. operates in the healthcare IT sector in the United States, Europe, and Japan. The company uses artificial intelligence (AI) to develop software products that manage medical imaging data in radiology, such as magnetic resonance imaging, computed tomography scans, X-ray, and ultrasound images, and licenses such products to healthcare providers and original equipment manufacturers. Its healthcare data solutions include ENDEX, a medical imaging solution that standardizes and structures data from medical images; and ENCOG, a solution designed to de-identify medical imaging data while retaining clinically relevant information.
Enlitic, Inc. Fundamentals Summary
| ENL fundamental statistics | |
|---|---|
| Market cap | AU$34.55m |
| Earnings (TTM) | -AU$23.22m |
| Revenue (TTM) | AU$740.60k |
46.6x
P/S Ratio-1.5x
P/E RatioIs ENL overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ENL income statement (TTM) | |
|---|---|
| Revenue | US$495.92k |
| Cost of Revenue | US$806.45k |
| Gross Profit | -US$310.53k |
| Other Expenses | US$15.24m |
| Earnings | -US$15.55m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.18 |
| Gross Margin | -62.62% |
| Net Profit Margin | -3,135.89% |
| Debt/Equity Ratio | 0% |
How did ENL perform over the long term?
See historical performance and comparison